{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-277418","form_type":"8-K","ticker":"GH","cik":"0001576280","company_name":"Guardant Health, Inc.","filed_at":"2023-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.602076+00:00","generated_at":"2026-06-08T02:24:18.811346+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Guardant Health hit with $83.4M patent infringement verdict; will appeal","bullets":["Jury found willful infringement of two patents; awarded $83.4M in damages (6% royalty on past sales).","Plaintiffs may seek up to treble damages (≈$250M) based on the willfulness finding.","Guardant strongly disagrees, plans post-trial motions and appeal to Federal Circuit.","Company says verdict unlikely to materially impact business but may require future royalty payments if upheld.","Case: TwinStrand Biosciences, Inc. and Univ. of Washington v. Guardant Health, C.A. No. 21-1126-GBW-SRF."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-277418","json":"https://secwatch.observer/filing/0001193125-23-277418.json","markdown":"https://secwatch.observer/filing/0001193125-23-277418.md","text":"https://secwatch.observer/filing/0001193125-23-277418.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576280/000119312523277418/0001193125-23-277418-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576280/000119312523277418/d850613d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T02:24:18.811346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}